Development of a take-home naloxone program at an urban academic emergency department
Autor: | Patrick M. Lank, Katherine C. Allen, Howard S. Kim, Danielle M. McCarthy, Daniel S. Cruz, Vidya Eswaran |
---|---|
Rok vydání: | 2020 |
Předmět: |
Narcotic Antagonists
Pharmacist Pharmacology (nursing) Pharmacy 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Naloxone Evaluation methods medicine Humans Lack of knowledge 030212 general & internal medicine Program Development Pharmacology Chicago business.industry Opioid overdose Emergency department medicine.disease Opioid-Related Disorders Analgesics Opioid Program development Medical emergency Drug Overdose business Emergency Service Hospital medicine.drug |
Zdroj: | Journal of the American Pharmacists Association : JAPhA. 60(6) |
ISSN: | 1544-3450 |
Popis: | Objective To describe the development of an ED-based take-home naloxone (THN) program in which naloxone kits are dispensed directly to patients during ED discharge. Practice description Our THN program was carried out at an urban academic hospital in downtown Chicago, IL. The THN kits consisted of 3 vials of 0.4-mg naloxone and 3 sterile syringes and needles for intramuscular delivery. Any member of the ED team (e.g., physician, pharmacist, or nurse) could recommend naloxone dispensing for a patient; however only the treating ED physician served as the prescriber for record. The ED pharmacist provided bedside education on recognizing opioid overdose and administering naloxone. The naloxone kit was dispensed to the patient at no cost. Practice innovation This ED pharmacist-led naloxone dispensing model bypasses barriers to naloxone filling and ensures that patients walk out of the emergency department with naloxone in hand. Evaluation methods We report key metrics from the first 16 months of program implementation, including the number of ED visits for opioid overdose and THN kits dispensed. We further describe the key facilitators and barriers to program development. Results Over 16 months, our emergency department had 669 unique visits for opioid overdose, and we dispensed 168 THN kits (10.5 per month). We are aware of at least 3 cases in which our THN kits were used to reverse opioid overdose. We faced key informational barriers to program development, such as a lack of knowledge regarding the allowability of ED medication dispensing, as well as financial barriers, such as the need to obtain a supply of naloxone. We also recognized the key facilitators of success, such as early engagement with hospital leadership. Conclusion Implementing a successful THN program is possible in the ED setting, and individual hospital emergency departments seeking to build their own program may benefit from our report. |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.